174 related articles for article (PubMed ID: 16962996)
1. Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo.
Schallreuter KU; Gibbons NC; Zothner C; Elwary SM; Rokos H; Wood JM
Biochem Biophys Res Commun; 2006 Oct; 349(3):931-8. PubMed ID: 16962996
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner.
Schallreuter KU; Elwary S
Life Sci; 2007 May; 80(24-25):2221-6. PubMed ID: 17335854
[TBL] [Abstract][Full Text] [Related]
3. Presence of epidermal allantoin further supports oxidative stress in vitiligo.
Shalbaf M; Gibbons NC; Wood JM; Maitland DJ; Rokos H; Elwary SM; Marles LK; Schallreuter KU
Exp Dermatol; 2008 Sep; 17(9):761-70. PubMed ID: 18328088
[TBL] [Abstract][Full Text] [Related]
4. Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo.
Schallreuter KU; Elwary SM; Gibbons NC; Rokos H; Wood JM
Biochem Biophys Res Commun; 2004 Mar; 315(2):502-8. PubMed ID: 14766237
[TBL] [Abstract][Full Text] [Related]
5. Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates.
Schallreuter KU; Gibbons NC; Elwary SM; Parkin SM; Wood JM
Biochem Biophys Res Commun; 2007 Apr; 355(4):1069-74. PubMed ID: 17335779
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo.
Schallreuter KU; Gibbons NC; Zothner C; Abou Elloof MM; Wood JM
Biochem Biophys Res Commun; 2007 Aug; 360(1):70-5. PubMed ID: 17592724
[TBL] [Abstract][Full Text] [Related]
7. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress.
Hasse S; Gibbons NC; Rokos H; Marles LK; Schallreuter KU
J Invest Dermatol; 2004 Feb; 122(2):307-13. PubMed ID: 15009710
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo.
Spencer JD; Gibbons NC; Rokos H; Peters EM; Wood JM; Schallreuter KU
J Invest Dermatol; 2007 Feb; 127(2):411-20. PubMed ID: 16946714
[TBL] [Abstract][Full Text] [Related]
9. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
Schallreuter KU; Salem MA; Holtz S; Panske A
FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
[TBL] [Abstract][Full Text] [Related]
10. Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 1: Epidermal H2O2/ONOO(-)-mediated stress abrogates tryptophan hydroxylase and dopa decarboxylase activities, leading to low serotonin and melatonin levels.
Schallreuter KU; Salem MA; Gibbons NC; Martinez A; Slominski R; Lüdemann J; Rokos H
FASEB J; 2012 Jun; 26(6):2457-70. PubMed ID: 22415302
[TBL] [Abstract][Full Text] [Related]
11. The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo.
Spencer JD; Gibbons NC; Böhm M; Schallreuter KU
Endocrinology; 2008 Apr; 149(4):1638-45. PubMed ID: 18174282
[TBL] [Abstract][Full Text] [Related]
12. Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo.
Schallreuter KU; Rübsam K; Gibbons NC; Maitland DJ; Chavan B; Zothner C; Rokos H; Wood JM
J Invest Dermatol; 2008 Apr; 128(4):808-15. PubMed ID: 17943184
[TBL] [Abstract][Full Text] [Related]
13. Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: Epidermal H2O2/ONOO(-)-mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling.
Schallreuter KU; Salem MA; Gibbons NC; Maitland DJ; Marsch E; Elwary SM; Healey AR
FASEB J; 2012 Jun; 26(6):2471-85. PubMed ID: 22415306
[TBL] [Abstract][Full Text] [Related]
14. Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo.
Schallreuter KU; Krüger C; Rokos H; Hasse S; Zothner C; Panske A
Arch Dermatol Res; 2007 Aug; 299(5-6):225-30. PubMed ID: 17404749
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro evidence for epidermal H2O2-mediated oxidative stress in piebaldism.
Vafaee T; Rokos H; Salem MM; Schallreuter KU
Exp Dermatol; 2010 Oct; 19(10):883-7. PubMed ID: 19758321
[TBL] [Abstract][Full Text] [Related]
16. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
17. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).
Schallreuter KU; Moore J; Behrens-Williams S; Panske A; Harari M
Int J Dermatol; 2002 Aug; 41(8):482-7. PubMed ID: 12207762
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016
[TBL] [Abstract][Full Text] [Related]
19. Essential amino acids for the stability of human butyrylcholinesterase as predicted by CUPSAT server.
Thomas B; Boopathy R
In Silico Biol; 2008; 8(5-6):517-29. PubMed ID: 19374135
[TBL] [Abstract][Full Text] [Related]
20. Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: a genetic predisposition for an altered catalase in patients with vitiligo?
Wood JM; Gibbons NC; Chavan B; Schallreuter KU
Exp Dermatol; 2008 Apr; 17(4):366-71. PubMed ID: 18315617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
